Brand Name | Status | Last Update |
---|---|---|
novalgina | C200263 | 2024-11-04 |
novalgina acetaminophen pain and fever for childrens | C200263 | 2024-11-04 |
novalgina pediatrico cough and cold | C200263 | 2024-11-04 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Postoperative pain | D010149 | — | G89.18 | — | 2 | 3 | 8 | 12 | 25 |
Pain | D010146 | EFO_0003843 | R52 | — | 1 | 2 | 4 | 6 | 13 |
Chronic pain | D059350 | HP_0012532 | — | — | 1 | 1 | 1 | 1 | 4 |
Cesarean section | D002585 | — | — | — | — | — | 3 | — | 3 |
Neuralgia | D009437 | EFO_0009430 | — | — | — | 1 | 2 | — | 3 |
Anesthesia | D000758 | — | — | — | — | — | 1 | 2 | 3 |
Fever | D005334 | HP_0001945 | R50.9 | — | 1 | 1 | 1 | — | 3 |
Ischemic stroke | D000083242 | — | — | — | — | — | 1 | 1 | 2 |
Stroke | D020521 | EFO_0000712 | I63.9 | — | — | — | 1 | 1 | 2 |
Aortic aneurysm | D001014 | EFO_0001666 | I71.9 | — | — | — | 1 | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pancreatitis | D010195 | HP_0001733 | K85 | — | 1 | 1 | — | 3 | 4 |
Migraine disorders | D008881 | EFO_0003821 | G43 | — | — | 2 | — | 1 | 3 |
Headache | D006261 | HP_0002315 | R51 | — | — | 2 | — | 1 | 3 |
Impacted tooth | D014095 | HP_0011079 | K01.1 | — | — | 2 | — | — | 2 |
Sepsis | D018805 | HP_0100806 | A41.9 | — | — | 1 | — | — | 1 |
Wounds and injuries | D014947 | — | T14.8 | — | — | 1 | — | — | 1 |
Spinal cord injuries | D013119 | EFO_1001919 | — | — | — | 1 | — | — | 1 |
Gastroenteritis | D005759 | EFO_1001463 | K52.9 | — | — | 1 | — | — | 1 |
Agnosia | D000377 | HP_0030222 | F88 | — | — | 1 | — | — | 1 |
Anesthesia and analgesia | D000760 | — | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Acute pain | D059787 | — | R52 | — | 1 | — | — | 2 | 3 |
Q fever | D011778 | EFO_0005224 | A78 | — | 1 | — | — | — | 1 |
Covid-19 | D000086382 | — | — | — | 1 | — | — | — | 1 |
Respiratory distress syndrome | D012128 | EFO_1000637 | J80 | — | 1 | — | — | — | 1 |
Acute lung injury | D055371 | EFO_0004610 | — | — | 1 | — | — | — | 1 |
Newborn respiratory distress syndrome | D012127 | — | P22 | — | 1 | — | — | — | 1 |
Syndrome | D013577 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Drug interactions | D004347 | — | — | 2 | — | — | — | — | 2 |
Enzyme induction | D004790 | — | — | 1 | — | — | — | — | 1 |
Healthy volunteers/patients | — | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Gingival recession | D005889 | — | K06.0 | — | — | — | — | 5 | 5 |
Postoperative nausea and vomiting | D020250 | EFO_0004888 | — | — | — | — | — | 4 | 4 |
Vomiting | D014839 | HP_0002013 | R11.1 | — | — | — | — | 4 | 4 |
Tick-borne encephalitis | D004675 | EFO_1001309 | A84 | — | — | — | — | 3 | 3 |
Encephalitis | D004660 | HP_0002383 | — | — | — | — | — | 3 | 3 |
Analgesia | D000698 | — | — | — | — | — | — | 3 | 3 |
Tooth abrasion | D014072 | — | K03.1 | — | — | — | — | 3 | 3 |
Nausea | D009325 | HP_0002018 | R11.0 | — | — | — | — | 2 | 2 |
Vitreoretinal surgery | D057586 | — | — | — | — | — | — | 2 | 2 |
Lyme disease | D008193 | — | A69.2 | — | — | — | — | 1 | 1 |
Drug common name | Dipyrone |
INN | — |
Description | Metamizole sodium is an organic sodium salt of antipyrine substituted at C-4 by a methyl(sulfonatomethyl)amino group, commonly used as a powerful analgesic and antipyretic. It has a role as a non-narcotic analgesic, an antirheumatic drug, a peripheral nervous system drug, an antipyretic, a prodrug, a cyclooxygenase 3 inhibitor and an anti-inflammatory agent. It contains a metamizole(1-). |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | Cc1c(N(C)CS(=O)(=O)[O-])c(=O)n(-c2ccccc2)n1C.O.[Na+] |
PDB | — |
CAS-ID | 68-89-3 |
RxCUI | 1537943 |
ChEMBL ID | CHEMBL3989803 |
ChEBI ID | — |
PubChem CID | 522325 |
DrugBank | DB04817 |
UNII ID | — |